Skip to content Skip to footer

AI

Advancements in Artificial Intelligence for Variant Pathogenicity Prediction in Genetic Disorders

The human genome harbors numerous subtle sequence variations, termed variants, which influence protein synthesis within cellular processes. Among these, only a minority exert deleterious effects on protein function, thereby contributing to pathological conditions. Identifying such pathogenic variants amidst the abundance of benign alterations represents a longstanding challenge in genomic medicine. Prior methodologies, including genome-wide association…

Read more

Exclusive: Dr. Ariel Ionescu on the microRNA-126 Breakthrough That’s Giving New Hope to ALS

Ariel Ionescu, the scientist who co-founded Rinnerva Therapeutics and has spent years developing a truly innovative therapy for amyotrophic lateral sclerosis (ALS), sat down with Nicolae Tomescu. In this exclusive interview for SLA România – first published on NEUROOTS.co – Dr. Ionescu gives the straight answers to the questions that matter most to the ALS…

Read more

🧬 Born from a quest for profound remedies, NEUROOTS transforms neurological challenges into opportunities for growth. Through the Neuroots Foundation, we’re transforming personal struggles into a collective movement—ensuring that everyone diagnosed has access to the resources, support, and hope they need to keep fighting.

NEUROOTS © 2026. All Rights Reserved.